Raymond D. Pratt

Biography

 Raymond D. Pratt, M.D, 66, is the Chief Medical Officer since he joined the company in April, 2012. Dr. Pratt was Vice President R&D and as the scientific leader in its Emerging Business and Renal Business Units at Shire PLLC.  Previous roles at Shire included Vice President Global Clinical Medicine and Global Clinical Affairs and head of US Clinical Development.  Dr. Pratt was instrumental in the FDA approval of Fosrenol ESRD indication and CKD non-dialysis indication in the European Union and United States.  He was responsible for three new drug applications as well as multiple EU applications.  He has managed ten different drugs through all stages of global development for renal and other indications and has extensive experience appearing before the FDA.  Prior to Shire, Dr. Pratt was Senior Director, Clinical Research and Development at Eisai Medical Research from 1994 to 2003, where he was head of Central Nervous System and Internal Medicine clinical development.  Dr. Pratt received his M.D. from the University of Illinois College of Medicine and completed his nephrology fellowship at the Walter Reed Army Medical Center and served as the Asst. Chief of Nephrology Services and Director of Dialysis Services.  He has served as an Assistant Professor Johns Hopkins University Department of Medicine and Nephrology from 1989 to 1993.

Research Interest

 Clinical Affairs,Clinical Development,drug applications,Clinical Research and Development